Screening for potential novel probiotic Lactobacillus strains based on high dipeptidyl peptidase IV and α-glucosidase inhibitory activity

Journal of Functional Foods

Volumn 20, Issue , 2016, Pages 486-495

  Zeng, Zhu ^a   Luo, Junyi ^a   Zuo, Fanglei ^a   Zhang, Ying ^a   Ma, Huiqin ^a   Chen, Shangwu ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Diabetes; Dipeptidyl peptidase IV; DPP IV inhibition; Lactobacillus; Probiotic; glucosidase inhibition

Indexed keywords

EID: 84953455707     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2015.11.030     Document Type: Article

References (54)

1. Argyri A.A., Zoumpopoulou G., Karatzas K.A., Tsakalidou E., Nychas G.J.E., Panagou E.Z., Tassou C.C. Selection of potential probiotic lactic acid bacteria from fermented olives by in vitro tests. Food Microbiology 2013, 33:282-291.
2. Baboota R.K., Bishnoi M., Ambalam P., Kondepudi K.K., Sarma S.M., Boparai R.K., Podili K. Functional food ingredients for the management of obesity and associated co-morbidities - A review. Journal of Functional Foods 2013, 5:997-1012.
3. Boots J.W.P. Protein hydrolysate enriched in peptides inhibiting DPP-IV and their use 2009, Patent 11/722, 667; US 2009/ 0075904; Campina Nederland Holding B.V., Amsterdam, The Netherlands.
4. Bron P.A., Molenaar D., de Vos W.M., Kleerebezem M. DNA micro-array-based identification of bile-responsive genes in Lactobacillus plantarum. Journal of Applied Microbiology 2006, 100:728-738.
5. Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., Gibson G.R., Delzenne N.M. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50:2374-2383.
6. Chen P., Zhang Q., Dang H., Liu X., Tian F., Zhao J., Chen Y., Zhang H., Chen W. Oral administration of Lactobacillus rhamnosus CCFM0528 improves glucose tolerance and cytokine secretion in high-fat-fed, streptozotocin-induced type 2 diabetic mice. Journal of Functional Foods 2014, 10:318-326.
7. Chen P., Zhang Q.X., Dang H., Liu X.M., Tian F.W., Zhao J.X., Chen Y.Q., Zhang H., Chen W. Screening for potential new probiotic based on probiotic properties and α-glucosidase inhibitory activity. Food Control 2014, 35:65-72.
8. Chiasson J.L., Josse R.G., Gomis R., Hanefeld M., Karasik A., Laakso M. Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial. Lancet 2002, 359:2072-2077.
9. Collado M.C., Isolauri E., Salminen S., Sanz Y. The impact of probiotic on gut health. Current Drug Metabolism 2009, 10:68-78.
10. Deacon C.F. Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: A comparative review. Diabetes Obesity & Metabolism 2011, 13:7-18.
11. Drucker D.J., Nauck M.A. The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006, 368:1696-1705.
12. FAO/WHO Guidelines for the Evaluation of Probiotics in Food, Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food 2002, London, ON, Canada.
13. Gao Y.Y., Zhang Y., Zhu J.M., Li B., Li Z., Zhu W.L., Shi J.Y., Jia Q., Li Y.M. Recent progress in natural products as DPP-4 inhibitors. Future Medical Chemistry 2015, 7:1079-1089.
14. Gomes A.C., Bueno A.A., de Souza R.G.M., Mota J.F. Gut microbiota, probiotics and diabetes. Nutrition Journal 2014, 13:60.
15. Hansawasdi C., Kawabata J., Kasai T. Hibiscus acid as an inhibitor of starch digestion in the Caco-2 cell model system. Bioscience, Biotechnology, and Biochemistry 2001, 65:2087-2089.
16. Harnedy P.A., O'Keeffe M.B., FitzGerald R.J. Purification and identification of dipeptidyl peptidase (DPP) IV inhibitory peptides from the macroalga Palmaria palmata. Food Chemistry 2015, 172:400-406.
17. Hatanaka T., Inoue Y., Arima J., Kumagai Y., Usuki H., Kawakami K., Kimura M., Mukaihara T. Production of dipeptidyl peptidase IV inhibitory peptides from defatted rice bran. Food Chemistry 2012, 134:797-802.
18. Huang S.L., Jao C.L., Ho K.P., Hsu K.C. Dipeptidyl-peptidase IV inhibitory activity of peptides derived from tuna cooking juice hydrolysates. Peptides 2012, 35:114-121.
19. Imamura K., Tsuyama Y., Hirata T. Identification and characterization of a novel fermented substance produced by edible Aspergillus oryzae AO-1 that inhibits DPP-IV activity. Journal of Bioscience and Bioengineering 2011, 111:37-40.
20. Kim S.H., Jo S.H., Kwon Y.I., Hwang J.K. Effects of onion (Allium cepa L.) extract administration on intestinal α-glucosidase activities and spikes in postprandial blood glucose levels in SD rats model. International Journal of Molecular Sciences 2011, 12:3757-3769.
21. Konrad B., Anna D., Marek S., Marta P., Aleksandra Z., Jozefa C. The evaluation of dipeptidyl peptidase (DPP)-IV, α-glucosidase and angiotensin converting enzyme (ACE) inhibitory activities of whey proteins hydrolyzed with serine protease isolated from Asian pumpkin (Cucurbita ficifolia). International Journal of Peptide Research and Therapeutics 2014, 20:483-491.
22. Lacroix I.M.E., Li-Chan E.C.Y. Dipeptidyl peptidase-IV inhibitory activity of dairy protein hydrolysates. International Dairy Journal 2012, 25:97-102.
23. Lacroix I.M.E., Li-Chan E.C.Y. Inhibition of dipeptidyl peptidase (DPP)-IV and α-glucosidase activities by pepsin-treated whey proteins. Journal of Agricultural and Food Chemistry 2013, 61:7500-7506.
24. Leverrier P., Dimova D., Pichereau V., Auffray Y., Boyaval P., Jan G. Susceptibility and adaptive response to bile salts in Propionibacterium freudenreichii: Physiological and proteomic analysis. Applied and Environmental Microbiology 2003, 69:3809-3818.
25. Li-Chan E.C.Y., Huang S.L., Jao C.L., Ho K.P., Hsu K.C. Peptides derived from Atlantic salmon skin gelatin as dipeptidyl peptidase IV inhibitors. Journal of Agricultural and Food Chemistry 2012, 60:973-978.
26. Liong M.T., Shah N.P. Bile salt deconjugation ability, bile salt hydrolase activity and cholesterol co-precipitation ability of lactobacilli strains. International Dairy Journal 2005, 15:391-398.
27. Matsui T., Yoshimoto C., Osajima K., Oki T., Osajima Y. In vitro survey of α-glucosidase inhibitory food components. Bioscience, Biotechnology, and Biochemistry 1996, 60:2019-2022.
28. +-ATPase activity in Bifidobacterium with special reference to acid tolerance. International Journal of Food Microbiology 2004, 93:109-113.
29. Mazziotti G., Gazzaruso C., Giustina A. Diabetes in Cushing syndrome: Basic and clinical aspects. Trends Endocrinology and Metabolism 2011, 22:499-506.
30. Mentlein R. Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regulatory Peptides 1999, 85:9-24.
31. Miyoshi M., Ogawa A., Higurashi S., Kadooka Y. Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice. European Journal of Nutrition 2014, 53:599-606.
32. Mochida T., Hira T., Hara H. The corn protein, zein hydrolysate, administered into the ileum attenuates hyperglycemia via its dual action on glucagon-like peptide-1 secretion and dipeptidyl peptidase-IV activity in rats. Endocrinology 2010, 151:3095-3104.
33. Muganga L., Liu X.M., Tian F.W., Zhao J.X., Zhang H., Chen W. Screening for lactic acid bacteria based on antihyperglycaemic and probiotic potential and application in synbiotic set yoghurt. Journal of Functional Foods 2015, 16:125-136.
34. Nongonierma A.B., FitzGerald R.J. Dipeptidyl peptidase IV inhibitory and antioxidative properties of milk protein-derived dipeptides and hydrolysates. Peptides 2013, 39:157-163.
35. Nongonierma A.B., FitzGerald R.J. Inhibition of dipeptidyl peptidase IV (DPP-IV) by proline containing casein-derived peptides. Journal of Functional Foods 2013, 5:1909-1917.
36. Oki T., Matsui T., Osajima Y. Inhibitory effect of α-glucosidase inhibitors varies according to its origin. Journal of Agricultural and Food Chemistry 1999, 47:550-553.
37. Panwar H., Calderwood D., Grant I.R., Grover S., Green B.D. Lactobacillus strains isolated from infant faeces possess potent inhibitory activity against intestinal alpha-and beta-glucosidases suggesting anti-diabetic potential. European Journal of Nutrition 2014, 53:1465-1474.
38. Panwar H., Rashmi H.M., Batish V.K., Grover S. Probiotics as potential biotherapeutics in the management of type 2 diabetes-prospects and perspectives. Diabetes/Metabolism Research and Reviews 2013, 29:103-112.
39. Ramchandran L., Shah N.P. Effect of exopolysaccharides and inulin on the proteolytic, angiotensin-I-converting enzyme- and α-glucosidase inhibitory activities as well as on textural and rheological properties of low-fat yogurt during refrigerated storage. Dairy Science and Technology 2009, 89:583-600.
40. Sales P.M., Souza P.M., Simeoni L.A., Magalhaes P.O., Silveira D. α-Amylase inhibitors: A review of raw material and isolated compounds from plant source. Journal of Pharmacy and Pharmaceutical Sciences 2012, 15:141-183.
41. Schägger H. Tricine-SDS-PAGE. Nature Protocols 2006, 1:16-22.
42. Silveira S.T., Martínez-Maqueda D., Recio I., Hernández-Ledesma B. Dipeptidyl peptidase-IV inhibitory peptides generated by tryptic hydrolysis of a whey protein concentrate rich in β-lactoglobulin. Food Chemistry 2013, 141:1072-1077.
43. Thomas C.M., Versalovic J. Probiotics-host communication: Modulation of signaling pathways in the intestine. Gut Microbes 2010, 1:148-163.
44. Tulipano G., Cocchi D., Caroli A.M. Comparison of goat and sheep β-lactoglobulin to bovine β-lactoglobulin as potential source of dipeptidyl peptidase IV (DPP-4) inhibitors. International Dairy Journal 2012, 24:97-101.
45. Uenishi H., Kabuki T., Seto Y., Serizawa A., Nakajima H. Isolation and identification of casein-derived dipeptidyl-peptidase 4 (DPP-4)-inhibitory peptide LPQNIPPL from gouda-type cheese and its effect on plasma glucose in rats. International Dairy Journal 2012, 22:24-30.
46. Verdenelli M.C., Ghelfi F., Silvi S., Orpianesi C., Cecchini C., Cresci A. Probiotic properties of Lactobacillus rhamnosus and Lactobacillus paracasei isolated from human faeces. European Journal of Nutrition 2009, 48:355-363.
47. Verspohl E.J. Novel therapeutics for type 2 diabetes: Incretin hormone mimetics (glucagons-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors. Pharmacology &Therapeutics 2009, 124:113-138.
48. Xie Y., An H.R., Hao Y.L., Qin Q.Q., Huang Y., Luo Y.B., Zhang L.B. Characterization of an anti-Listeria bacteriocin produced by Lactobacillus plantarum LB-B1 isolated from koumiss, a traditionally fermented dairy product from China. Food Control 2011, 22:1027-1031.
49. Yu Z., Yin Y., Zhao W., Yu Y., Liu B., Liu J., Chen F. Novel peptides derived from egg white protein inhibiting alpha-glucosidase. Food Chemistry 2011, 129:1376-1382.
50. Zeng Z., Luo J.Y., Zuo F.L., Yu R., Zhang Y., Ma H.Q., Chen S.W. Bifidobacteria possess inhibitory activity against dipeptidyl peptidase (DPP)-IV. Letters in Applied Microbiology 2015, 10.1111/lam.12510.
51. Zhang Y., Chen R., Ma H.Q., Chen S.W. Isolation and identification of dipeptidyl peptidase IV-Inhibitory peptides from trypsin/chymotrypsin-treated goat milk casein hydrolysates by 2D-TLC and LC-MS/MS. Journal of Agriculture and Food Chemistry 2015, 63:8819-8828.
52. Zhang Y., Chen R., Zuo F.L., Ma H.Q., Zhang Y.C., Chen S.W. Comparison of dipeptidyl peptidase IV-inhibitory activity of peptides from bovine and caprine milk casein by in silico and in vitro analyses. International Dairy Journal 2015, 10.1016/j.idairyj.2015.10.001.
53. Zhang Y., Wang L.F., Zhang J.C., Li Y.X., He Q.W., Li H., Guo X., Guo J.X., Zhang H.P. Probiotic Lactobacillus casei Zhang ameliorates high-fructose-induced impaired glucose tolerance in hyperinsulinemia rats. European Journal of Nutrition 2014, 53:221-232.
54. Zuo F.L., Feng X.J., Chen L.L., Chen S.W. Identification and partial characterization of lactic acid bacteria isolated from traditional dairy products produced by herders in the western Tianshan Mountains of China. Letters in Applied Microbiology 2014, 59:549-555.